Basic Information
PECA Labs is reimagining the vascular grafts and valves space with durable polymer cardiovascular devices designed to fit, grow, and last, helping patients avoid repeat surgeries and reduce morbidity and mortality. PECA's proprietary technologies, including controlled expandable grafts and low-thrombogenic polymer membranes, are based on a proprietary tunable polymer materials platform, representing a new approach to engineering synthetic materials with greater durability and customization compared to currently available cardiac implants. The company’s grafts and catheters are designed for extended longevity compared to existing products, thanks to their resistance to thrombosis, calcification, and immune response, as well as offering growth potential, customization, and non-invasive visualization.
Peca Labs, Inc.
Pittsburgh,Pennsylvania,United States of America
less than 15 people
January 01, 2011
--
peca@PECALabs.com

